5-Thiazolecarboxylic Acid, 2-Amino-, Methyl Ester

In cGMP intermediate synthesis for heterocyclic drug candidates, the methyl ester is preferentially activated by acylation of the primary amine with a chloro-substituted pyrimidine. Typically, 2.5 kg of 5-Thiazolecarboxylic Acid, 2-Amino-, Methyl Ester is charged to a 100 L glass-lined reactor, dissolved in 20 L anhydrous DMF, and treated with 1.05 equivalents of diisopropylethylamine. The mixture is cooled to −5 °C under nitrogen, and 1.02 equivalents of 2,4-dichloropyrimidine dissolved in 5 L DMF are added via a dosing pump at a rate controlled to keep internal temperature below 2 °C. After addition, the batch is allowed to warm to 20 °C and monitored by reverse-phase HPLC; typical reaction completion is 3–4 hours. The crude product is quenched into 100 L deionized water, extracted with ethyl acetate, and washed with brine. Solvent replacement with isopropanol under vacuum, followed by controlled cooling from 70 °C to 5 °C at 0.3 °C/min, yields needle-like crystals. Vacuum filtration through a 0.5 m² Hastelloy Nutsche filter and drying in a double-cone rotary vacuum dryer at 45 °C and 25 mbar reduces residual DMF to below 880 ppm, compliant with ICH Q3C Class 2 solvent limits. The isolated intermediate—a 2-(pyrimidin-2-ylamino)thiazole-5-carboxylic acid methyl ester—routinely achieves >99.5% HPLC area purity with a single unknown impurity below 0.10% and the regioisomer below 0.15%. Further saponification of the ester with lithium hydroxide in THF/water (3:1) at 0 °C yields the free acid, which is coupled with an aniline derivative via HATU/DIPEA activation to generate a clinical FGFR kinase inhibitor framework. The entire sequence is executed under ICH Q7 QA oversight, with in-process controls referenced to USP <621> and genotoxic impurity risk assessments per ICH M7.

How the Methyl Ester Functions in Succinate Dehydrogenase Inhibitor Synthesis

Conversion of the methyl ester into an amide-linked building block is the pivotal step in assembling modern SDHI fungicide pharmacophores. In a 500 L enamel-lined vessel equipped with a reflux condenser and jacket cooling, 15 kg of the amino ester is dissolved in 120 kg dichloromethane together with 1.5 equivalents of triethylamine. The solution is cooled to 0–5 °C, and 1.1 equivalents of a halogenated nicotinoyl chloride—typically 2-chloronicotinoyl chloride—in 30 kg dichloromethane are metered in over 90 minutes while maintaining the jacket at −10 °C. The exothermic formation of the amide demands precise addition rate control; exceeding 8 °C batch temperature triggers precipitation of a viscous triethylammonium hydrochloride sludge that fouls the temperature probe and retards mixing. After an aqueous work-up with 5% sodium bicarbonate to remove excess acid chloride, the organic phase is distilled under atmospheric pressure and the residue crystallised from 2:1 cyclohexane/ethyl acetate to give the amide intermediate in 87–92% yield. The ester group subsequently undergoes selective ammonolysis with 7 N ammonia in methanol in a pressure reactor at 60 °C and 4 bar for 8 hours to yield the primary carboxamide. Final condensation with a substituted aniline using a mixed anhydride method—isobutyl chloroformate and N-methylmorpholine in THF at −15 °C—completes the core. The finished SDHI active ingredient meets FAO AGP:CP/382 specification, with a total related-substance count not exceeding 2.0% and a single impurity capped at 0.5%. Kilo-lab thermal hazard evaluation via RC1e reaction calorimetry reveals an adiabatic temperature rise of 38 °C for the amidation; commercial scale operation therefore requires a 4:1 safety margin on jacket cooling capacity. The formulated product delivers curative and protectant activity against Phakopsora pachyrhizi at application rates of 75–100 g a.i./ha, and degradation half-life in loam soil at 20 °C is 65 days as per OECD 307.

Incorporation of the heterocyclic ester into polyester backbones via transesterification establishes a route to high-Tg coating binders with pronounced metal adhesion. Trials on a co-rotating twin-screw reactive extruder (screw diameter 25 mm, L/D 48, segmented conveying and kneading elements) involve a feed blend of the thiazole methyl ester, 1,4-cyclohexanedimethanol, and a minor triol branching agent at a diol/ester molar ratio of 0.98:1. Titanium tetrabutoxide at 0.05 mol% relative to ester is injected as a 3% solution in isopropanol into barrel zone 2. The temperature profile across 10 barrel zones ramps from 180 °C to 245 °C; a vent port at zone 8 is connected to a vacuum pump maintaining <1 mbar to strip methanol and accelerate chain extension. Residence time is controlled at 4–6 minutes by adjusting screw speed in the range 150–250 rpm. The melt is pelletized under dry nitrogen and dried to a moisture content of <0.02% before further processing; failure to achieve this leads to hydrolytic degradation at re-melt and a drop in intrinsic viscosity exceeding 0.05 dL/g. The resulting polyester exhibits a glass transition temperature (ASTM D3418, DSC, 20 °C/min heating rate) of 84 °C, approximately 12–14 °C higher than a cyclohexanedimethanol terephthalate analogue of comparable molecular weight. When formulated into a solvent-based coil coating primer with a blocked aliphatic isocyanate crosslinker at NCO:OH = 1.05:1, cured at 232 °C peak metal temperature for 50 seconds, the film develops a König pendulum hardness (ASTM D4366) of 167 seconds after 24-hour ambient conditioning, versus 142 seconds for a non-thiazole control. Methyl ethyl ketone double rub resistance (ASTM D5402, 1 kg load) exceeds 200 cycles without substrate breakthrough, and crosshatch adhesion (ISO 2409) on chromated aluminium remains Gt 0. The system carries compliance with Qualicoat Class 2 specifications, though its weatherability under QUV-B 313 requires a 2% UVA/HALS package to prevent moderate yellowing beyond 1000 hours.

Performance Thresholds in Closed-Loop Cooling Water Formulations

When pre-hydrolysed in dilute sodium hydroxide to the water-soluble carboxylate, the methyl ester derivative functions as a copper corrosion inhibitor suitable for recirculating cooling systems operating in the pH 8.0–9.2 range. The hydrolysis step is carried out batch-wise in a 200 L stainless steel vessel by stirring the solid ester in 1.02 equivalents of 2 N NaOH at 60 °C until a clear, pale-yellow solution forms; the carboxylate stock is then diluted to a 10% active solution and metered into the cooling loop by a diaphragm dosing pump. Effective protection of C11000 copper coupons is attained at a residual concentration of 25–35 mg/L, as determined by UV spectrophotometry at 278 nm after filtration through a 0.45 µm membrane. The inhibitor forms a chemisorbed film through the thiazole nitrogen and carboxylate oxygen, replacing labile chloride adlayers. Over a 14-day semidynamic test following ASTM D1384-18, the weight-loss data in synthetic cooling water (150 ppm CaCO₃ hardness, 200 ppm chloride, 40 °C, 0.6 m/s flow velocity) show a threshold behaviour that plateaus above 30 mg/L. The table below summarises the corrosion rates under these specific conditions.

The protective film exhibits a catastrophic breakdown once free chlorine, introduced during biocide shock-dosing, exceeds 0.5 mg/L for more than 4 hours; chloramine-mediated degradation of the thiazole ring opens the structure and releases soluble copper carboxylate species that plate onto zinc anodes in galvanic couples. For this reason, tandem application with trichloroisocyanuric acid or sodium hypochlorite pulses must be sequenced such that the inhibitor is replenished 12–24 hours after the oxidant residual decays below 0.1 mg/L. In combination with tolyltriazole at 10 mg/L, the total copper inhibition programme meets the Electric Power Research Institute’s criterion of <0.5 µm/year for mixed-metallurgy systems, but formulation incompatibility with zirconium-based phosphonate deposits has been noted during high-hardness incursions.

Condensation with cyanuric chloride in a water-acetone slurry at 0–5 °C and maintained pH 5.5–6.0 produces a key dichlorotriazinyl intermediate for stilbene-derived optical brighteners. A 0.05 molar portion of the methyl ester is suspended in 200 mL acetone, diluted with 200 mL ice-water, and treated with 0.055 mol of finely powdered cyanuric chloride added in five equal portions over 60 minutes. Sodium carbonate solution (10%) is fed via a pH-stat controller to neutralise the generated HCl. After the complete dissolution of cyanuric chloride, the first condensation product is not isolated; instead, an equimolar amount of disodium 4,4′-diaminostilbene-2,2′-disulfonate dissolved in water is introduced at 40 °C and pH 7.0–7.5 for the second condensation, which links two thiazole ester units to the stilbene core. A final morpholine substitution at 90 °C and pH 9.0 for 5 hours displaces the remaining chlorine, yielding the tetrasulfonated fluorescent whitening agent. Isolation by salting-out with sodium chloride at 20% w/v, filtration, and vacuum drying gives a free-flowing powder with a molar extinction coefficient at 350 nm exceeding 4.5×10⁴ L·mol⁻¹·cm⁻¹. Commercial application at 0.05–0.15% owf during polyester exhaust dyeing under high-temperature conditions (130 °C, 30 minutes) imparts a CIE whiteness index increase of 35–40 points relative to untreated substrate. The whitener’s ADME profile is assessed per OECD 205 Daphnia immobilisation test, and batch release includes HPLC-MS fingerprinting against a reference standard to control by-product bisanilino impurities.

When Heterobifunctional Crosslinkers Leverage Primary Amine Reactivity

Conjugation of the primary amine with a maleimide-functionalised NHS ester crosslinker opens a manifold for site-directed bioconjugation under physiological pH. In a typical protocol, the methyl ester is first dissolved at 1 mM in anhydrous DMSO and then diluted to 0.1 mM in 50 mM phosphate-buffered saline, pH 7.4, containing 20% DMF to maintain solubility. A 10-fold molar excess of succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) is added in a single portion, and the mixture is vortexed gently at 22 °C for 60 minutes. The reaction is quenched by adding 50 mM Tris-HCl, pH 8.0, to inactivate unreacted NHS ester. Excess crosslinker is removed by size-exclusion chromatography on a Superdex peptide column equilibrated with 100 mM phosphate, 5 mM EDTA, pH 6.8. The maleimide-activated hapten is then combined with a reduced antibody fragment—engineered with an interchain disulfide selectively reduced by 2.5 mM tris(2-carboxyethyl)phosphine at 37 °C for 90 minutes—at a hapten:thiol molar ratio of 8:1. Conjugation proceeds at 4 °C overnight under argon. Hydrophobic interaction chromatography–HPLC analysis reveals a drug-derivative-antibody ratio of 1.7–2.1, and residual free crosslinker is confirmed below 5 ppm by LC-MS/MS in compliance with guideline ICH M7. The final conjugate is sterile-filtered through a 0.22 µm PVDF membrane and formulated into histidine-sucrose buffer, pH 6.0, for cryostability. End-use assessment as a diagnostic hapten in an ELISA system reports a limit of detection of 0.08 ng/mL against the target immunoglobulin, with cross-reactivity below 0.5% for structural analogues when the ester is retained as a spacer arm precluding steric occlusion of the epitope.